<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> contribute to the atherosclerotic process that includes stiffening of large peripheral arteries </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast, our laboratory previously reported a paradoxical increase in cerebrovascular compliance in LDLr(-/-):hApoB(+/+) atherosclerotic (ATX) mice (7) </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that prevention of cerebral artery <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> with a <z:hpo ids='HP_0011010'>chronic</z:hpo> dietary <z:chebi fb="11" ids="22586">antioxidant</z:chebi> intake would normalize the changes in cerebral artery wall structure and biomechanics and prevent the decline in basal cerebral blood flow associated with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Three-month-old ATX mice were treated, or not, for 3 mo with the <z:chebi fb="0" ids="26195">polyphenol</z:chebi> <z:chebi fb="0" ids="15600">(+)-catechin</z:chebi> (CAT; 30 mg·kg(-1)·day(-1)) and compared with <z:mp ids='MP_0002169'>wild-type</z:mp> controls </plain></SENT>
<SENT sid="4" pm="."><plain>In isolated, pressurized cerebral arteries from ATX mice, CAT prevented <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> (deterioration of endothelium-dependent, flow-mediated dilations; P &lt; 0.05), the inward hypertrophic structural remodeling (increase in the wall-to-lumen ratio; P &lt; 0.05), and the rise in cerebrovascular compliance (rightward shift of the stress-strain curve measured in passive conditions, reflecting mechanical properties of the arterial wall; P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Doppler optical coherence tomography imaging in vivo confirmed these findings, showing that cerebral compliance was higher in ATX mice and normalized by CAT (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>CAT also prevented basal <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> in ATX mice (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Active remodeling of the cerebrovascular wall in ATX mice was further suggested by the increase (P &lt; 0.05) in pro-metalloproteinase-9 activity, which was normalized by CAT </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that, by preserving the endothelial function, a <z:hpo ids='HP_0011010'>chronic</z:hpo> treatment with CAT prevents the deleterious effect of severe <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> on cerebral artery wall structure and biomechanical properties, contributing to preserving resting cerebral blood flow </plain></SENT>
</text></document>